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Abstract
Background: The high prevalence of chronic diseases in Western countries implies that the presence of multiple
chronic diseases within one person is common. Especially at older ages, when the likelihood of having a chronic
disease increases, the co-occurrence of distinct diseases will be encountered more frequently. The aim of this study
was to estimate the age-specific prevalence of multimorbidity in the general population. In particular, we
investigate to what extent specific pairs of diseases cluster within people and how this deviates from what is to be
expected under the assumption of the independent occurrence of diseases (i.e., sheer coincidence).
Methods: We used data from a Dutch health survey to estimate the prevalence of pairs of chronic diseases
specified by age. Diseases we focused on were diabetes, myocardial infarction, stroke, and cancer. Multinomial P-
splines were fitted to the data to model the relation between age and disease status (single versus two diseases).
To assess to what extent co-occurrence cannot be explained by independent occurrence, we estimated observed/
expected co-occurrence ratios using predictions of the fitted regression models.
Results: Prevalence increased with age for all disease pairs. For all disease pairs, prevalence at most ages was
much higher than is to be expected on the basis of coincidence. Observed/expected ratios of disease
combinations decreased with age.
Conclusion: Common chronic diseases co-occur in one individual more frequently than is due to chance. In
monitoring the occurrence of diseases among the population at large, such multimorbidity is insufficiently taken
into account.
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Introduction
The prevalence of chronic diseases has increased strongly
the last few decades in most Western countries [1,2].
Besides aging of the population, this is also partly due to
increased survival in people with many chronic conditions
[3,4]. Given the high prevalence of chronic diseases, it is
not surprising that the presence of multiple chronic dis-
eases within one person has also become more common
[5]. This phenomenon is known as multimorbidity, or as
comorbidity if one disease is considered as the primary, or
index, condition [6]. Even if we assume that diseases are
distributed randomly and occur independently of each
other, we expect a great share of multimorbidity at older
ages [7,8]. For instance, if 20% of those 65 years or older
suffer from diabetes mellitus (DM) and if the prevalence
of osteoarthritis is 20% in this group, 4% will suffer from
both diabetes and osteoarthritis by sheer coincidence.
Clustering of diseases in individuals is to be expected for
several reasons [6,9]. First, as mentioned, on the basis of
coincidence, and second, because some diseases are
known to be causally related. For instance, diabetes is a
risk factor for acute myocardial infarction (AMI) and
stroke (cerebrovascular accident [CVA]) and, therefore,
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these diseases will be more common among diabetics.
Thirdly, clustering of diseases can result from the presence
of common underlying known or unknown risk factors, as
many risk factors (e.g., smoking and BMI) are related to
multiple chronic diseases. And finally, diseases tend to
cluster within individuals due to differences in individual
susceptibility to disease. In elderly people, this is often
referred to as frailty [10].
Multimorbidity is often used as an explanatory variable
in research to adjust for “case mix,” or as a determinant
of prognosis of the main disease of interest [11]. How-
ever, the view that multimorbidity is an object of study in
itself is gaining support [9,12]. Since people with multi-
morbidity have an increased mortality risk, higher health
care utilization, and greater quality of life losses than
people with a single disease [13], any description of the
distribution of diseases in the population at large is
incomplete without estimates of how often combinations
of chronic diseases occur. Moreover, as the co-occur-
rence of common chronic diseases is more frequent than
is to be expected on the basis of chance, monitoring of
the prevalence of multimorbidity seems a logical thing to
do in an aging society. In this manner, it might be possi-
ble to better identify groups at increased risk, to identify
new risk factors that specifically apply to comorbidity,
and thus to devise appropriate public health interven-
tions. Furthermore, given the current attention on medi-
cal guidelines and disease management programs, it is
crucial to take multimorbidity into account [9,14,15].
The associations between some specific pairs of dis-
eases have been investigated in more detail, in particular
causally-related diseases. Thus, in numerous studies the
occurrence of diseases, such as coronary heart disease
and stroke in diabetics, has been investigated [16-18].
Much less is known about the clustering of other dis-
ease combinations, such as heart disease and cancer, in
the general population. Another issue that has rarely
been addressed explicitly is the role of age [19]. Even
though it is to be expected that the prevalence of multi-
morbidity increases with age, it would be interesting to
gain more insight into the nature of this relation, and
how this, in turn, relates to the age-dependence of the
prevalence of the individual diseases. In this article we
compare the joint occurrence of pairs of four of the
most prevalent chronic diseases (diabetes, AMI, cancer,
and stroke), and we focus especially on the role of age.
We estimate to what extent specific pairs of diseases
cluster within people and how this deviates from what is
to be expected under the assumption of independence.
Methodology
Data
We used data from the Permanent Survey of Living
Conditions (POLS: Permanent Onderzoek LeefSituatie)
covering the years 2001 to 2007. POLS is an ongoing
yearly cross-sectional survey, started in 1981 and coordi-
nated by Statistics Netherlands [20]. The POLS survey
data, which require no ethics approval, is publicly avail-
able from http://www.dans.knaw.nl. POLS monitors
developments in lifestyle, health, medical consumption,
preventive behavior, and well-being in the Netherlands.
Before 1997, the surveys used to be sampled with house-
holds as the underlying unit. Since 1997, surveys have
been sampled on the basis of person records from a
centralized municipal registry. The interviewer visits the
participants at home, asks for informed consent and
leaves a written (drop-off) questionnaire. Yearly net par-
ticipation currently ranges around 10,000 individuals,
with response percentages of around 60%. In the POLS
surveys in the years 2001 to 2007, the following ques-
tions on disease status were included:
1. Diabetes: Do you have diabetes?
2. Stroke: Did you ever experience a stroke, cerebral
hemorrhage, or cerebral infarction?
3. AMI: Did you ever experience a myocardial
infarction?
4. Cancer: Did you ever have a cancer?
With four diseases included, there are a total of six
different pairs of diseases: diabetes and AMI, diabetes
and stroke, diabetes and cancer, AMI and stroke, AMI
and cancer, and stroke and cancer. Table 1 displays
characteristics of the survey for the different years.
Methods
For each combination of two diseases (disease A and
disease B), a variable was created that could take on the
following values: 0 (no disease), 1 (only disease A), 2
(only disease B), 3 (both diseases). These variables were
entered as the dependent variable in a multinomial
regression simultaneously estimating the following prob-
abilities: P(no A, no B), P(A, no B), P(no A, B), and P(A,
B). In order to derive a smooth relation between age
and these probabilities from the rough data, we used P-
spline smoothing [21]. P-splines are a combination of B-
splines and penalized regression. The method may be
Table 1 Characteristics of the POLS survey, 2001-2007
Year N % Men % Diabetes % Stroke % AMI % Cancer
2001 9676 49.2 3.4 1.7 2.6 4.4
2002 9744 48.3 3.2 2.1 3 3.9
2003 9877 49.3 3.6 2.3 2.9 4.6
2004 11117 48.9 3.9 2 3 5.4
2005 10378 48.9 4.4 2.4 3.1 6
2006 9607 49.0 4.4 2.4 2.8 5.5
2007 8741 48.3 4.8 2.5 2.9 5.9
2001-2007 69140 48.9 4.0 2.2 2.9 5.1
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described briefly as follows. First, one defines a large
number of equally-spaced cubic B-spline functions over
the age interval. B-splines are polynomial functions that
have a non-zero value only within a specified range. Fig-
ure 1 displays the cubic B-spline basis functions used in
our analyses, which are equally spaced nonoverlapping
third order polynomial functions.
A key feature of cubic B-splines is that any linear
combination of the basis functions will result in a
smooth function with a second-order derivative that is
continuous at the joining points. Cubic B-splines share
the advantage of dummy variables (local basis) and
polynomials (smoothness) without their disadvantages.
For dummy variables, a disadvantage is that the age
gradient would not be smooth, while with polynomials,
values at high ages can strongly influence the fit at
lower ages. The drawback of B-splines and other forms
of local regression is that it is difficult to determine
the number of knots and spacing of the basis func-
tions. As a solution to this problem, P-splines were
proposed. The general idea behind P-splines is to use a
relatively large number of knots and to put a penalty
on the difference between the coefficients of adjacent
cubic B-spline functions. The optimal amount of
smoothing in P-splines is then determined by adjusting
the weight of the penalty using cross-validation or an
information criterion. In our analyses, the optimal
smoothing parameters were found by minimizing the
Aikaike Information Criterion (in Additional file 1
results are presented when the Bayesian information is
used instead). All analyses were done in R http://www.
r-project.org
Outcome measures
In this paper, we will focus on three outcome measures
for which we will present age-specific estimates based
on predictions of the six estimated multinomial regres-
sion models. First, we will present estimates of the pre-
valence of pairs of diseases. Second, to asses on an
absolute scale to what extent co-occurrence cannot be
explained by independent occurrence, we calculated
observed minus expected co-occurrence for each pair of
diseases in the following manner:
Obs− Exp = P(A,B) - P(A)*P(B)
= P(A,B) - { P(A, no B) + P(A,B)} *{ P(no A,B) + P(A,B)}
with P(A, B) as the observed proportion and the
expected proportion being P(A) times P(B). Expected
prevalence of pairs of diseases was calculated on the
assumption of independence. Third, to asses the relative
deviation from independent co-occurrence, we estimated
observed/expected co-occurrence ratios:
Obs/Exp =
P(A,B)
P(A)*P(B)
=
P(A,B)
{ P(A, no B) + P(A,B)} *{ P(no A,B) + P(A,B)}
Confidence intervals around these outcome measures
were calculated using Monte Carlo simulations. Regres-
sion coefficients of the regression models were repeat-
edly drawn from a multivariate normal distribution
(sample size was set at 10,000). For each draw of the
regression coefficients, predictions were made and
observed/expected differences and ratios were calcu-
lated. After all draws were performed, confidence inter-
vals were obtained by taking the 2.5th and 97.5th
percentiles of the outcome measures.
Results
Figure 2 displays the data and predictions of the six
multinomial regression models that were estimated (it
should be noted that we omitted the estimates for the
level “none of the two diseases” from the figures, which
is simply the complement of the other categories).
From Figure 2 it can be seen that, in general, preva-
lence for all diseases and disease combinations increases
with age, but that the rate of increase is lower (or even
negative) at higher ages. If we look, for instance, at the
upper left panel of Figure 2, at age 80 years about 12%
of people have diabetes without ever having experienced
a stroke, about 7% of people have experienced a stroke
but do not have diabetes, and about 2% of the 80 year
olds have diabetes and a history of stroke.
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Figure 1 Cubic B-spline basis functions used for P-spline
smoothing (each number indicates a different B-spline basis
function).
van Baal et al. Population Health Metrics 2011, 9:51
http://www.pophealthmetrics.com/content/9/1/51
Page 3 of 9
In Figure 3, the prevalence of all six pairs of diseases
is displayed. From Figure 3, it can be seen that the pre-
valence of pairs of diseases increases with age and that
the pair of greatest prevalence for most ages is diabetes
in combination with AMI, and the pair of smallest pre-
valence is CVA in combination with cancer.
Figure 4 displays observed minus expected joint dis-
ease prevalence, indicating to what extent diseases co-
occur more often than is to be expected under the
assumption of independence. From Figure 4 it can be
seen that for disease combinations without cancer,
observed minus expected co-occurrence of disease pairs
increases with age. For combinations of diseases includ-
ing cancer, observed minus expected co-occurrence is
negative in an age range roughly from 60 to 75 or 80
years. The absolute degree of “unexpected” co-occur-
rence is highest for the combination diabetes and AMI.
To appreciate the uncertainty surrounding this out-
come measure, Figure 5 displays confidence intervals
around observed minus expected co-occurrence for all
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Figure 2 Model predictions and data as a function of age for the six multinomial regression models (numbers indicate age-specific
proportions observed in a particular year in the POLS survey).
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disease pairs. What can be seen from Figure 5 is that
uncertainty increases with the level of unexpected co-
occurrence as it increases with age. The level of co-
occurrence in the disease pairs including cancer often is
not significantly different from zero.
Figure 6 displays the ratios of the observed/expected
joint prevalences. From this graph it can be seen that,
although at lower ages co-occurrence of chronic diseases
seems rare in an absolute sense, they tend to cluster
much more, as can be inferred from the decreasing
ratios. In line with Figures 4 and 5, the observed/
expected ratios for disease pairs with cancer are less
than one for the age range 60 to 80 years.
Figure 7 displays confidence intervals around
observed/expected ratios for all disease pairs. What can
be seen from this graph is that at low ages, uncertainty
surrounding the ratios is very large due to a small num-
ber of cases, and uncertainty decreases at higher ages. In
accordance with Figure 5, for most age ranges, ratios
involving cancer were not significantly different from 1.
Discussion and conclusions
In this study, we estimated the age-specific joint preva-
lence of all pairs of four of the most prevalent chronic
diseases in the Dutch population. Co-occurrence of all
disease pairs studied was seen to increase with age. The
joint prevalence was highest for diabetes and AMI,
while cancer and stroke co-occurred the least frequently.
For all pairs not including cancer, co-occurrence was
more frequent for all age groups than expected when
the individual diseases occur independently. Thus,
observed minus expected proportions increased with
age, while the corresponding observed/expected ratios
became smaller. This implies that although at lower
ages co-occurrence is less prevalent, at lower ages
chronic diseases tend to cluster more within individuals.
Diabetes co-occurred frequently with stroke and AMI,
which is in line with what is known about the increased
risk for these diseases in diabetics. On a relative scale,
as measured by the observed/expected ratio, stroke and
AMI co-occurred most frequently. This is not surpris-
ing, as both events are related in their etiology and
share multiple underlying risk factors such as high
blood pressure, cholesterol, smoking, and obesity. Can-
cer, however, seemed to display a somewhat different
behavior: within an age range of approximately 60 to 75
years, it co-occurred less frequently than expected with
the other three diseases. This pattern was somewhat
unexpected and not easy to interpret. On the face of it,
this seems to imply that diabetes and cardiovascular dis-
eases “protect” against cancer and/or vice versa. How-
ever, to the best of our knowledge, there is no known
patho-physiological mechanism that could explain such
a relation. Alternatively, it could be a “survivor” effect:
those prone to develop both diseases die of cardiovascu-
lar disease before reaching the age at which cancer
would become symptomatic. Yet another explanation
might be that people adapt their lifestyles after being
diagnosed with cancer. It needs to be stressed that the
uncertainty in these estimates is large, and that the find-
ings regarding cancer can be due to chance. Although
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interesting, at this point we cannot attach much signifi-
cance to this observation.
A limitation of our study was that the institutionalized
population was not included in the survey. As the pre-
valence of chronic diseases is probably higher among
those institutionalized [22], this exclusion is likely to
have led to some degree of underestimation of the pre-
valence of co-occurrence of chronic diseases. Further-
more, the response rate in this survey was not much
more than 60%, which is a potential source of bias.
Also, the self-reported nature of the data may have
induced some bias in different ways. First, people might
not accurately report their disease status. However, pre-
vious studies showed that self-reports of chronic condi-
tions were fairly accurate, suggesting that this form of
bias probably remained limited [23,24]. Second, if non-
response was related to disease status, bias would result.
To investigate whether this was the case, we compared
our estimates to other national representative estimates
of diagnosed disease prevalence [1,25,26]. Although
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Figure 5 Model predictions of observed disease pair prevalence minus expected disease pair prevalence with 95% prediction
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estimates of cancer and diabetes prevalence were very
similar, our estimates for AMI and stroke appear to be
high. This could possibly be explained by a less-strin-
gent case definition. Third, even if people report accu-
rately and there is no selective nonresponse,
undiagnosed cases will be missed. In case of diabetes, it
has been argued that for every diagnosed diabetes case,
there may be around 0.5 to one undiagnosed case.
Thus, the true prevalences include, depending on the
type of disease and other factors, variable proportions of
people with no current morbidity or disability. Although
there has been an upward trend in the ratio of undiag-
nosed/diagnosed cases of diabetes in the Netherlands
[27], there are no recent observational studies in the
Netherlands that have presented estimates of disease
co-occurrence among diabetics. If there still is substan-
tial underdiagnosis, we hypothesize that having a dia-
betes diagnosis is more likely in people with
comorbidity. This would imply that our estimates of
observed/expected ratios could be too high. Other lim-
itations of our analyses are that cancer was treated as a
single entity, whereas it is heterogeneous condition, and
that no distinction was made between diabetes Types 1
and 2.
A few remarks are necessary regarding the method we
used in modeling the joint presence of two diseases in
the same individuals. Most importantly, we aimed at
expressing prevalence as a function of age. With two
diseases there are four possibilities. Hence, the outcome
variable has a multinomial distribution, which we related
to age using P-splines. The advantage of P-splines
compared to polynomial regression is that model fit at
the lower ages is not influenced by that at higher ages,
and vice versa. That is, P-splines can be seen as a form
of “local” regression. Furthermore, with P-splines it is
not necessary to choose a more or less arbitrary number
of knots, which is often seen as a drawback of other
types of splines, such as B-splines. The choice of the
smoothing parameter(s) for P-splines is data driven. In
our analyses, we used the Akaike information criterion
(AIC) criterion, which was also used by Eilers and Marx
[21]. In Additional file 1, results are shown when the
Bayesian information criterion (BIC) is used to find the
optimal smoothing parameter. In general, the results are
similar, but a bit smoother and less wiggly when the
BIC criterion is used compared to the AIC criterion. For
the absolute co-occurrence prevalence, the estimates do
not differ much between the AIC and BIC. However, for
the observed/expected ratios, there is a clear influence
at lower ages, in which the prevalences are generally
low. The observed/expected ratios at those ages are
much higher if the BIC is used. Finally, it should be
noted that in order to increase power, we combined
both sexes and pooled all years. This means that the
estimates are time- and gender-averaged. Stratifying the
analyses by sex and analyzing time trends would there-
fore be a next step.
Although the “clustering” of chronic diseases is not a
surprise, quantitative data on multimorbidity are scarce.
Especially at older ages, the co-occurrence of chronic
conditions starts to become so common that individuals
with more than one disease can no longer be considered
the exception. This not only has consequences for dis-
ease management programs, but also guidelines should
more explicitly address the issue of comorbidity than
has hitherto been done. The fact that the care for this
category of patients poses specific difficulties requiring a
distinctive approach is still insufficiently recognized. A
better appreciation of the epidemiology of multimorbid-
ity is a first step to bring the magnitude of the problem
into focus. A noteworthy point of our study is that we
have presented estimates combining cancer with non-
cancerous diseases. Although cancer incidence and pre-
valence are usually well-monitored by cancer
registrations, these are not often linked to noncancerous
diseases.
In conclusion, in this study we quantified age-specific
co-occurrence patterns. It is clear that with increasing
age, multimorbidity becomes common. More impor-
tantly, the prevalence of multimorbidity most of the
time is much greater than would be the case if diseases
occur independently from each other. Thus, the practice
in epidemiological and public health research to monitor
individual diseases tells only part of the story. With an
aging population, it is important to quantify the problem
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of multimorbidity. Those involved in the management of
care, the drafters of guidelines, and the doctors treating
patients with more than one disease should develop
strategies to improve the care for this category of
patients that is becoming more numerous as the popula-
tion ages.
Additional material
Additional file 1: Additional file 1shows the results if the Bayesian
information criterion (BIC) is used to find the optimal smoothing
parameters for the P-splines.
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